Understanding Cardiovascular Events With JAK Inhibitors: Similarities and Differences of the Vascular Effects Between Different JAK Inhibitors on Endothelial Cells Exposed to Inflammatory Cytokines

Documenti analoghi

• JAK Inhibitors for Treatment of SAPHO Syndrome: A Systematic Review of 72 Cases
  di: Patrick Fazeli, et al.
  Pubblicazione: (2025)
• Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry
  di: Joshua F. Baker, et al.
  Pubblicazione: (2025)
• Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human Disease
  di: Rachel E. Twomey, et al.
  Pubblicazione: (2024)
• Chronicity of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno‐Oncology Database
  di: Alexandra Ladouceur, et al.
  Pubblicazione: (2025)
• Endothelial Dysfunction in Systemic Sclerosis: The Passive Leg Movement Technique in the Assessment of Nitric Oxide–Mediated Vascular Impairment
  di: Silvia Guella, et al.
  Pubblicazione: (2026)